Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Little Rock, Arkansas 72202


Purpose:

Many children with end stage renal disease develop hyperlipidemia.HMG-CoA reductase inhibitors, such as pravastatin, are typical treatments for hyperlipidemia. However, we do not know how pravastatin is metabolized in patients on dialysis. This study is designed to provide preliminary pharmacokinetic data for pravastatin in pediatric patients on peritoneal dialysis.


Criteria:

Inclusion Criteria: 1. Patients from 12 months to 18 years of age. 2. Patients with end stage renal disease who receive continuous cycling peritoneal dialysis. 3. signed informed consent 4. Physical exam demonstrates no abnormalities that would make this study medically hazardous to the subject. - Exclusion Criteria: 1. Any clinically significant unstable medical condition or chronic disease other than those associated with ESRD. 2. Any clinically significant illness within 10 days or receiving single-sdoe of study medication 3. History of rhabdomyolysis 4. Clinically significant liver disease or history of malabsorption or previous gastrointestinal surgery that could effect drug absorption or metabolism. 5. Clinical laboratory abnormalities: AST,ALT, CPK > 2.5 times upper limit of normal; hemoglobin < 8.5 g.dL. 6. Known hypersensitivity to pravastatin 7. Unwilling to have blood samples drawn 8. Has taken a HMG-CoA reductase inhibitor in the last week -


NCT ID:

NCT00571194


Primary Contact:

Principal Investigator
Eileen N Ellis, MD
Arkansas Children's Hospital Research Institute


Backup Contact:

N/A


Location Contact:

Little Rock, Arkansas 72202
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 17, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.